Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference59 articles.
1. Stafinski T, Menon D, Philippon DJ, et al. Health technology funding decision-making processes around the world. Pharmacoeconomics. 2011;29(6):475–95.
2. Byford S, Raftery J. Economics notes. Perspectives in economic evaluation. BMJ. 1998;316(7143):1529–30.
3. Kind P, Hardman G, Macran S. UK population norms for EQ-5D: discussion paper 172. York: Centre for Health Economics, University of York; 1999.
4. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. London: NICE; 2013.
5. Salas-Vega S, Bertling A, Mossialos E. A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK. Health Policy. 2016;120(10):1104–14.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献